-
2
-
-
0023907075
-
Development of techniques for the detection of blood doping in sport
-
Berglund B. Development of techniques for the detection of blood doping in sport. Sports Med. 5(2), 127-135 (1988).
-
(1988)
Sports Med.
, vol.5
, Issue.2
, pp. 127-135
-
-
Berglund, B.1
-
3
-
-
0020319934
-
Blood doping and related issues: A brief review
-
Gledhill N. Blood doping and related issues: A brief review. Med. Sci. Sports Exerc. 14(3), 183-189 (1982).
-
(1982)
Med. Sci. Sports Exerc.
, vol.14
, Issue.3
, pp. 183-189
-
-
Gledhill, N.1
-
4
-
-
0023120533
-
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin Results of a combined Phase I and II clinical trial
-
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined Phase I and II clinical trial. N. Engl. J. Med. 316(2), 73-78 (1987).
-
(1987)
N. Engl. J. Med.
, vol.316
, Issue.2
, pp. 73-78
-
-
Eschbach, J.W.1
Egrie, J.C.2
Downing, M.R.3
Browne, J.K.4
Adamson, J.W.5
-
5
-
-
0033624047
-
A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes
-
Parisotto R, Gore CJ, Emslie KR et al. A novel method utilising markers of altered erythropoiesis for the detection of recombinant human erythropoietin abuse in athletes. Haematologica 85(6), 564-572 (2000).
-
(2000)
Haematologica
, vol.85
, Issue.6
, pp. 564-572
-
-
Parisotto, R.1
Gore, C.J.2
Emslie, K.R.3
-
6
-
-
0342646961
-
Recombinant erythropoietin in urine
-
Lasne F, De Ceaurriz J. Recombinant erythropoietin in urine. Nature 405(6787), 635 (2000).
-
(2000)
Nature
, vol.405
, Issue.6787
, pp. 635
-
-
Lasne, F.1
De Ceaurriz, J.2
-
8
-
-
0035895071
-
Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin
-
Skibeli V, Nissen-Lie G, Torjesen P. Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin. Blood 98(13), 3626-3634 (2001).
-
(2001)
Blood
, vol.98
, Issue.13
, pp. 3626-3634
-
-
Skibeli, V.1
Nissen-Lie, G.2
Torjesen, P.3
-
9
-
-
0035716187
-
Structural analysis of sulfated N-linked oligosaccharides in erythropoietin
-
Kawasaki N, Haishima Y, Ohta M et al. Structural analysis of sulfated N-linked oligosaccharides in erythropoietin. Glycobiology 11(12), 1043-1049 (2001).
-
(2001)
Glycobiology
, vol.11
, Issue.12
, pp. 1043-1049
-
-
Kawasaki, N.1
Haishima, Y.2
Ohta, M.3
-
10
-
-
84864490702
-
Erythropoietin - Influence of physical strain and application on concentration in blood and urine
-
4). Schänzer W (Ed. Sport und Buch Strauss, Cologne, Germany, 319-321
-
Breidbach A, Platen P, Schänzer W. Erythropoietin - influence of physical strain and application on concentration in blood and urine. In: RECENT Advances in Doping Analysis (4). Schänzer W (Ed.). Sport und Buch Strauss, Cologne, Germany, 319-321 (1997).
-
(1997)
Recent Advances in Doping Analysis
-
-
Breidbach, A.1
Platen, P.2
Schänzer, W.3
-
11
-
-
0037114935
-
Detection of isoelectric profiles of erythropoietin in urine: Differentiation of natural and administered recombinant hormones
-
Lasne F, Martin L, Crepin N, De Ceaurriz J. Detection of isoelectric profiles of erythropoietin in urine: Differentiation of natural and administered recombinant hormones. Anal. Biochem. 311(2), 119-126 (2002).
-
(2002)
Anal. Biochem.
, vol.311
, Issue.2
, pp. 119-126
-
-
Lasne, F.1
Martin, L.2
Crepin, N.3
De Ceaurriz, J.4
-
12
-
-
0035400290
-
Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures
-
Lasne F. Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J. Immunol. Methods 253(1-2), 125-131 (2001).
-
(2001)
J. Immunol. Methods
, vol.253
, Issue.1-2
, pp. 125-131
-
-
Lasne, F.1
-
13
-
-
67649222109
-
Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures
-
Lasne F. Double-blotting: A solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. Methods Mol. Biol. 536, 213-219 (2009).
-
(2009)
Methods Mol. Biol.
, vol.536
, pp. 213-219
-
-
Lasne, F.1
-
14
-
-
47749093921
-
Identification of zinc-alpha-2- glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS
-
Reichel C. Identification of zinc-alpha-2- glycoprotein binding to clone AE7A5 antihuman EPO antibody by means of nano-HPLC and high-resolution high-mass accuracy ESI-MS/MS. J. Mass Spectrom. 43(7), 916-923 (2008).
-
(2008)
J. Mass Spectrom.
, vol.43
, Issue.7
, pp. 916-923
-
-
Reichel, C.1
-
15
-
-
34250809530
-
Isoelectric profiles of human erythropoietin are different in serum and urine
-
Lasne F, Martin L, Martin JA, De Ceaurriz J. Isoelectric profiles of human erythropoietin are different in serum and urine. Int. J. Biol. Macromol. 41(3), 354-357 (2007).
-
(2007)
Int. J. Biol. Macromol.
, vol.41
, Issue.3
, pp. 354-357
-
-
Lasne, F.1
Martin, L.2
Martin, J.A.3
De Ceaurriz, J.4
-
16
-
-
0014949207
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
-
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259), 680-685 (1970).
-
(1970)
Nature
, vol.227
, Issue.5259
, pp. 680-685
-
-
Laemmli, U.K.1
-
17
-
-
0030945210
-
A probable conformational difference between recombinant and urinary erythropoietins
-
Kung CK, Goldwasser E. A probable conformational difference between recombinant and urinary erythropoietins. Proteins 28(1), 94-98 (1997).
-
(1997)
Proteins
, vol.28
, Issue.1
, pp. 94-98
-
-
Kung, C.K.1
Goldwasser, E.2
-
18
-
-
77953674493
-
Towards the screening of urinary EPO by SDS-PAGE analysis
-
15). Schänzer et al. (Eds Sportverlag Strauss, Cologne, Germany
-
Desharnais P, Ayotte C. Towards the screening of urinary EPO by SDS-PAGE analysis. In: RECENT Advances in Doping Analysis (15). Schänzer et al. (Eds). Sportverlag Strauss, Cologne, Germany (2007).
-
(2007)
Recent Advances in Doping Analysis
-
-
Desharnais, P.1
Ayotte, C.2
-
19
-
-
77449130942
-
Erythropoietin and analogs
-
Reichel C, Gmeiner G. Erythropoietin and analogs. Handb. Exp. Pharmacol. 2010(195), 251-294 (2010).
-
(2010)
Handb. Exp. Pharmacol.
, vol.2010
, Issue.195
, pp. 251-294
-
-
Reichel, C.1
Gmeiner, G.2
-
20
-
-
38749137803
-
Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels
-
Kohler M, Ayotte C, Desharnais P et al. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels. Int. J. Sports Med. 29(1), 1-6 (2008).
-
(2008)
Int. J. Sports Med.
, vol.29
, Issue.1
, pp. 1-6
-
-
Kohler, M.1
Ayotte, C.2
Desharnais, P.3
-
21
-
-
65749093331
-
SDS-PAGE of recombinant and endogenous erythropoietins: Benefits and limitations of the method for application in doping control
-
Reichel C, Kulovics R, Jordan V, Watzinger M, Geisendorfer T. SDS-PAGE of recombinant and endogenous erythropoietins: Benefits and limitations of the method for application in doping control. Drug Test. Anal. 1(1), 43-50 (2009).
-
(2009)
Drug Test. Anal.
, vol.1
, Issue.1
, pp. 43-50
-
-
Reichel, C.1
Kulovics, R.2
Jordan, V.3
Watzinger, M.4
Geisendorfer, T.5
-
22
-
-
77950567285
-
Sarcosyl-Page: A new method for the detection of Mircera®- and EPO-doping in blood
-
Reichel C, Abzieher F, Geisendorfer T. SARCOSYL-PAGE: A new method for the detection of Mircera®- and EPO-doping in blood. Drug Test. Anal. 1(11-12), 494-504 (2009).
-
(2009)
Drug Test. Anal.
, vol.1
, Issue.11-12
, pp. 494-504
-
-
Reichel, C.1
Abzieher, F.2
Geisendorfer, T.3
-
23
-
-
84855245023
-
The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design
-
Reichel C. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design. Drug Test. Anal. 3(11-12), 883-891 (2011).
-
(2011)
Drug Test. Anal.
, vol.3
, Issue.11-12
, pp. 883-891
-
-
Reichel, C.1
-
24
-
-
78650654549
-
Defending Dynepo® detection
-
Gmeiner G, Reichel C, Kulovics R, Scheiblhofer V. Defending Dynepo® detection. Drug Test. Anal. 2(11-12), 526-532 (2010).
-
(2010)
Drug Test. Anal.
, vol.2
, Issue.11-12
, pp. 526-532
-
-
Gmeiner, G.1
Reichel, C.2
Kulovics, R.3
Scheiblhofer, V.4
-
25
-
-
54249163993
-
Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo®
-
Llop E, Gutiérrez-Gallego R, Segura J, Mallorquí J, Pascual JA. Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo®). Anal. Biochem. 383(2), 243-254 (2008).
-
(2008)
Anal. Biochem.
, vol.383
, Issue.2
, pp. 243-254
-
-
Llop, E.1
Gutiérrez-Gallego, R.2
Segura, J.3
Mallorquí, J.4
Pascual, J.A.5
-
26
-
-
77953858371
-
IEF pattern classification-derived criteria for the identification of epoetin-delta in urine
-
Lamon S, Boccard J, Sottas PE et al. IEF pattern classification-derived criteria for the identification of epoetin-delta in urine. Electrophoresis 31(12), 1918-1924 (2010).
-
(2010)
Electrophoresis
, vol.31
, Issue.12
, pp. 1918-1924
-
-
Lamon, S.1
Boccard, J.2
Sottas, P.E.3
-
27
-
-
0034997401
-
Development and characterization of novel erythropoiesis stimulating protein (NESP)
-
Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br. J. Cancer 84(Suppl. 1), 3-10 (2001).
-
(2001)
Br. J. Cancer
, vol.84
, Issue.SUPPL.1
, pp. 3-10
-
-
Egrie, J.C.1
Browne, J.K.2
-
28
-
-
0036840574
-
Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin and endogenous erythropoietin from human urine
-
Catlin DH, Breidbach A, Elliott S, Glaspy J. Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin and endogenous erythropoietin from human urine. Clin. Chem. 48(11), 2057-2059 (2002).
-
(2002)
Clin. Chem.
, vol.48
, Issue.11
, pp. 2057-2059
-
-
Catlin, D.H.1
Breidbach, A.2
Elliott, S.3
Glaspy, J.4
-
29
-
-
33750973533
-
Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease
-
Macdougall IC, Robson R, Opatrna S et al. Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease. Clin. J. Am. Soc. Nephrol. 1(6), 1211-1215 (2006).
-
(2006)
Clin. J. Am. Soc. Nephrol.
, vol.1
, Issue.6
, pp. 1211-1215
-
-
Macdougall, I.C.1
Robson, R.2
Opatrna, S.3
-
30
-
-
66749138979
-
Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control
-
Lasne F, Martin L, Martin JA, De Ceaurriz J. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control. Haematologica 94(6), 888-890 (2009).
-
(2009)
Haematologica
, vol.94
, Issue.6
, pp. 888-890
-
-
Lasne, F.1
Martin, L.2
Martin, J.A.3
De Ceaurriz, J.4
-
31
-
-
68449104851
-
Effects of exercise on the isoelectric patterns of erythropoietin
-
Lamon S, Martin L, Robinson N, Saugy M, Ceaurriz J, Lasne F. Effects of exercise on the isoelectric patterns of erythropoietin. Clin. J. Sport Med. 19(4), 311-315 (2009).
-
(2009)
Clin. J. Sport Med.
, vol.19
, Issue.4
, pp. 311-315
-
-
Lamon, S.1
Martin, L.2
Robinson, N.3
Saugy, M.4
Ceaurriz, J.5
Lasne, F.6
-
32
-
-
80655149012
-
How to confirm C.E.R.A. doping in athletes' blood
-
Leuenberger N, Lamon S, Robinson N, Giraud S, Saugy M. How to confirm C.E.R.A. doping in athletes' blood? Forensic Sci. Int. 213(1-3), 101-103 (2011).
-
(2011)
Forensic Sci. Int.
, vol.213
, Issue.1-3
, pp. 101-103
-
-
Leuenberger, N.1
Lamon, S.2
Robinson, N.3
Giraud, S.4
Saugy, M.5
-
33
-
-
70349183432
-
A high-throughput test to detect C.E.R.A doping in blood
-
Lamon S, Giraud S, Egli L et al. A high-throughput test to detect C.E.R.A. doping in blood. J. Pharm. Biomed. Anal. 50(5), 954-958 (2009).
-
(2009)
J. Pharm. Biomed. Anal.
, vol.50
, Issue.5
, pp. 954-958
-
-
Lamon, S.1
Giraud, S.2
Egli, L.3
-
34
-
-
33748690610
-
Preclinical evaluation of Hematide™, a novel erythropoiesis stimulating agent, for the treatment of anemia
-
Fan Q, Leuther KK, Holmes CP et al. Preclinical evaluation of Hematide™, a novel erythropoiesis stimulating agent, for the treatment of anemia. Exp. Hematol. 34(10), 1303-1311 (2006).
-
(2006)
Exp. Hematol.
, vol.34
, Issue.10
, pp. 1303-1311
-
-
Fan, Q.1
Leuther, K.K.2
Holmes, C.P.3
-
35
-
-
80655131163
-
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients
-
Macdougall IC, Wiecek A, Tucker B et al. Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients. Clin. J. Am. Soc. Nephrol. 6(11), 2579-2586 (2011).
-
(2011)
Clin. J. Am. Soc. Nephrol.
, vol.6
, Issue.11
, pp. 2579-2586
-
-
Macdougall, I.C.1
Wiecek, A.2
Tucker, B.3
-
36
-
-
33748679131
-
Evaluation of the safety and pharmacodynamics of Hematide™, a novel erythropoietic agent, in a Phase I, double-blind, placebo-controlled, dose-escalation study in healthy volunteers
-
Stead RB, Lambert J, Wessels D et al. Evaluation of the safety and pharmacodynamics of Hematide™, a novel erythropoietic agent, in a Phase I, double-blind, placebo-controlled, dose-escalation study in healthy volunteers. Blood 108(6), 1830-1834 (2006).
-
(2006)
Blood
, vol.108
, Issue.6
, pp. 1830-1834
-
-
Stead, R.B.1
Lambert, J.2
Wessels, D.3
-
37
-
-
34447636387
-
Hematide™ is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model
-
Woodburn KW, Fan Q, Winslow S et al. Hematide™ is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model. Exp. Hematol. 35(8), 1201-1208 (2007).
-
(2007)
Exp. Hematol.
, vol.35
, Issue.8
, pp. 1201-1208
-
-
Woodburn, K.W.1
Fan, Q.2
Winslow, S.3
-
38
-
-
84862532659
-
Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events
-
Green JM, Leu K, Worth A et al. Peginesatide and erythropoietin stimulate similar erythropoietin receptor-mediated signal transduction and gene induction events. Exp. Hematol. 40(7), 575-587 (2012).
-
(2012)
Exp. Hematol.
, vol.40
, Issue.7
, pp. 575-587
-
-
Green, J.M.1
Leu, K.2
Worth, A.3
-
39
-
-
70350433566
-
Police find range of drugs after trawling bins used by Tour De France cyclists
-
Benkimoun P. Police find range of drugs after trawling bins used by Tour De France cyclists. BMJ 339, b4201 (2009).
-
(2009)
BMJ
, vol.339
-
-
Benkimoun, P.1
-
41
-
-
80655124644
-
Methods for detection and confirmation of Hematide™/ peginesatide in anti-doping samples
-
Leuenberger N, Saugy J, Mortensen RB, Schatz PJ, Giraud S, Saugy M. Methods for detection and confirmation of Hematide™/ peginesatide in anti-doping samples. Forensic Sci. Int. 213(1-3), 15-19 (2011).
-
(2011)
Forensic Sci. Int.
, vol.213
, Issue.1-3
, pp. 15-19
-
-
Leuenberger, N.1
Saugy, J.2
Mortensen, R.B.3
Schatz, P.J.4
Giraud, S.5
Saugy, M.6
-
42
-
-
79959725994
-
Syn thesis, characterisation and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes
-
Möller I, Thomas A, Geyer H, Schänzer W, Thevis M. Synthesis, characterisation and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes. Rapid Commun. Mass Spectrom. 25(15), 2115-2123 (2011).
-
(2011)
Rapid Commun. Mass Spectrom.
, vol.25
, Issue.15
, pp. 2115-2123
-
-
Möller, I.1
Thomas, A.2
Geyer, H.3
Schänzer, W.4
Thevis, M.5
-
43
-
-
78751695383
-
Screen and confirmation of PEG-epoetin beta in equine plasma
-
Chang Y, Maylin GM, Matsumoto G, Neades SM, Catlin DH. Screen and confirmation of PEG-epoetin beta in equine plasma. Drug Test. Anal. 3(1), 68-73 (2011).
-
(2011)
Drug Test. Anal.
, vol.3
, Issue.1
, pp. 68-73
-
-
Chang, Y.1
Maylin, G.M.2
Matsumoto, G.3
Neades, S.M.4
Catlin, D.H.5
-
45
-
-
34548229364
-
Fcrn: The neonatal Fc receptor comes of age
-
Roopenian DC, Akilesh S. FcRn: The neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7(9), 715-725 (2007).
-
(2007)
Nat. Rev. Immunol.
, vol.7
, Issue.9
, pp. 715-725
-
-
Roopenian, D.C.1
Akilesh, S.2
-
46
-
-
0037025895
-
Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung
-
Spiekermann GM, Finn PW, Ward ES et al. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: Functional expression of FcRn in the mammalian lung. J. Exp. Med. 196(3), 303-310 (2002).
-
(2002)
J. Exp. Med.
, vol.196
, Issue.3
, pp. 303-310
-
-
Spiekermann, G.M.1
Finn, P.W.2
Ward, E.S.3
-
47
-
-
33750699277
-
Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway
-
Bitonti AJ, Dumont JA. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Adv. Drug Deliv. Rev. 58(9-10), 1106-1118 (2006).
-
(2006)
Adv. Drug Deliv. Rev.
, vol.58
, Issue.9-10
, pp. 1106-1118
-
-
Bitonti, A.J.1
Dumont, J.A.2
-
48
-
-
77957125273
-
Detection of His-tagged Long-R 3)-IGF-I in a black market product
-
Kohler M, Thomas A, Walpurgis K, Terlouw K, Schänzer W, Thevis M. Detection of His-tagged Long-R(3)-IGF-I in a black market product. Growth Horm. IGF Res. 20(5), 386-390 (2010).
-
(2010)
Growth Horm. IGF Res.
, vol.20
, Issue.5
, pp. 386-390
-
-
Kohler, M.1
Thomas, A.2
Walpurgis, K.3
Terlouw, K.4
Schänzer, W.5
Thevis, M.6
-
49
-
-
84870246919
-
Detection of EPO-Fc fusion protein in human blood: Screening and confirmation protocols for sports drug testing
-
In press
-
Reichel C, Thevis M. Detection of EPO-Fc fusion protein in human blood: Screening and confirmation protocols for sports drug testing. Drug Test. Anal. (2012) (In press).
-
(2012)
Drug Test. Anal.
-
-
Reichel, C.1
Thevis, M.2
-
50
-
-
0028816847
-
Purification and characterization of hypoxia-inducible factor 1
-
Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270(3), 1230-1237 (1995).
-
(1995)
J. Biol. Chem.
, vol.270
, Issue.3
, pp. 1230-1237
-
-
Wang, G.L.1
Semenza, G.L.2
-
51
-
-
0030968939
-
Targeting gene expression to hypoxic tumor cells
-
Dachs GU, Patterson AV, Firth JD et al. Targeting gene expression to hypoxic tumor cells. Nat. Med. 3(5), 515-520 (1997).
-
(1997)
Nat. Med.
, vol.3
, Issue.5
, pp. 515-520
-
-
Dachs, G.U.1
Patterson, A.V.2
Firth, J.D.3
-
52
-
-
0026468180
-
A nuclear factor induced by hypoxia via De novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
-
Semenza GL, Wang GL. A nuclear factor induced by hypoxia via De novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 12(12), 5447-5454 (1992).
-
(1992)
Mol. Cell. Biol.
, vol.12
, Issue.12
, pp. 5447-5454
-
-
Semenza, G.L.1
Wang, G.L.2
-
53
-
-
0029761644
-
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
-
Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16(9), 4604-4613 (1996).
-
(1996)
Mol. Cell. Biol.
, vol.16
, Issue.9
, pp. 4604-4613
-
-
Forsythe, J.A.1
Jiang, B.H.2
Iyer, N.V.3
-
54
-
-
77953854244
-
Hypoxic regulation of erythropoiesis and iron metabolism
-
Haase VH. Hypoxic regulation of erythropoiesis and iron metabolism. Am. J. Physiol. Renal Physiol. 299(1), F1-F13 (2010).
-
(2010)
Am. J. Physiol. Renal Physiol.
, vol.299
, Issue.1
-
-
Haase, V.H.1
-
55
-
-
70449527373
-
Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing
-
Webb JD, Coleman ML, Pugh CW. Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing. Cell Mol. Life Sci. 66(22), 3539-3554 (2009).
-
(2009)
Cell Mol. Life Sci.
, vol.66
, Issue.22
, pp. 3539-3554
-
-
Webb, J.D.1
Coleman, M.L.2
Pugh, C.W.3
-
56
-
-
0035917808
-
Targeting of HIF-alpha to the von Hippel- Lindau ubiquitylation complex by O2- regulated prolyl hydroxylation
-
Jaakkola P, Mole DR, Tian YM et al. Targeting of HIF-alpha to the von Hippel- Lindau ubiquitylation complex by O2- regulated prolyl hydroxylation. Science 292(5516), 468-472 (2001).
-
(2001)
Science
, vol.292
, Issue.5516
, pp. 468-472
-
-
Jaakkola, P.1
Mole, D.R.2
Tian, Y.M.3
-
57
-
-
34547493149
-
Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases
-
Bruegge K, Jelkmann W, Metzen E. Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases. Curr. Med. Chem. 14(17), 1853-1862 (2007).
-
(2007)
Curr. Med. Chem.
, vol.14
, Issue.17
, pp. 1853-1862
-
-
Bruegge, K.1
Jelkmann, W.2
Metzen, E.3
-
58
-
-
84862783287
-
Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents
-
Tanaka T, Nangaku M. Recent advances and clinical application of erythropoietin and erythropoiesis-stimulating agents. Exp. Cell Res. 318(9), 1068-1073 (2012).
-
(2012)
Exp. Cell Res.
, vol.318
, Issue.9
, pp. 1068-1073
-
-
Tanaka, T.1
Nangaku, M.2
-
59
-
-
65649123829
-
Erythropoiesis stimulating agents and techniques: A challenge for doping analysts
-
Jelkmann W. Erythropoiesis stimulating agents and techniques: A challenge for doping analysts. Curr. Med. Chem. 16(10), 1236-1247 (2009).
-
(2009)
Curr. Med. Chem.
, vol.16
, Issue.10
, pp. 1236-1247
-
-
Jelkmann, W.1
-
60
-
-
75149138761
-
Prolyl hydroxylases and therapeutics
-
Smith TG, Talbot NP. Prolyl hydroxylases and therapeutics. Antioxid. Redox Signal. 12(4), 431-433 (2010).
-
(2010)
Antioxid. Redox Signal.
, vol.12
, Issue.4
, pp. 431-433
-
-
Smith, T.G.1
Talbot, N.P.2
-
61
-
-
78649876180
-
Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD
-
Bernhardt WM, Wiesener MS, Scigalla P et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J. Am. Soc. Nephrol. 21(12), 2151-2156 (2010).
-
(2010)
J. Am. Soc. Nephrol.
, vol.21
, Issue.12
, pp. 2151-2156
-
-
Bernhardt, W.M.1
Wiesener, M.S.2
Scigalla, P.3
-
62
-
-
84870248829
-
Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis
-
doi:10.1002/ dta.390 Epub ahead of print
-
Beuck S, Schanzer W, Thevis M. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. Drug Test. Anal. doi:10.1002/ dta.390 (2012) (Epub ahead of print).
-
(2012)
Drug Test. Anal.
-
-
Beuck, S.1
Schanzer, W.2
Thevis, M.3
-
63
-
-
77955503450
-
Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis
-
Thevis M, Thomas A, Kohler M et al. Mass spectrometry-based characterization of new drugs and methods of performance manipulation in doping control analysis. Eur. J. Mass Spectrom. 16(3), 301-312 (2010).
-
(2010)
Eur. J. Mass Spectrom.
, vol.16
, Issue.3
, pp. 301-312
-
-
Thevis, M.1
Thomas, A.2
Kohler, M.3
-
64
-
-
84855248903
-
Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research
-
Beuck S, Bornatsch W, Lagojda A, Schänzer W, Thevis M. Development of liquid chromatography-tandem mass spectrometry-based analytical assays for the determination of HIF stabilizers in preventive doping research. Drug Test. Anal. 3(11-12), 756-770 (2011).
-
(2011)
Drug Test. Anal.
, vol.3
, Issue.11-12
, pp. 756-770
-
-
Beuck, S.1
Bornatsch, W.2
Lagojda, A.3
Schänzer, W.4
Thevis, M.5
-
65
-
-
82355177261
-
The use of genes for performance enhancement: Doping or therapy
-
Oliveira RS, Collares TF, Smith KR, Collares TV, Seixas FK. The use of genes for performance enhancement: Doping or therapy? Braz. J. Med. Biol. Res. 44(12), 1194-1201 (2011).
-
(2011)
Braz. J. Med. Biol. Res.
, vol.44
, Issue.12
, pp. 1194-1201
-
-
Oliveira, R.S.1
Collares, T.F.2
Smith, K.R.3
Collares, T.V.4
Seixas, F.K.5
-
66
-
-
80052423299
-
Blood doping and its detection
-
Jelkmann W, Lundby C. Blood doping and its detection. Blood 118(9), 2395-2404 (2011).
-
(2011)
Blood
, vol.118
, Issue.9
, pp. 2395-2404
-
-
Jelkmann, W.1
Lundby, C.2
-
67
-
-
0036785428
-
Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy
-
Binley K, Askham Z, Iqball S et al. Long-term reversal of chronic anemia using a hypoxia-regulated erythropoietin gene therapy. Blood 100(7), 2406-2413 (2002).
-
(2002)
Blood
, vol.100
, Issue.7
, pp. 2406-2413
-
-
Binley, K.1
Askham, Z.2
Iqball, S.3
-
68
-
-
4444305201
-
Genetic doping' with erythropoietin cDNA in primate muscle is detectable
-
Lasne F, Martin L, De Ceaurriz J, Larcher T, Moullier P, Chenuaud P. 'Genetic doping' with erythropoietin cDNA in primate muscle is detectable. Mol. Ther. 10(3), 409-410 (2004).
-
(2004)
Mol. Ther.
, vol.10
, Issue.3
, pp. 409-410
-
-
Lasne, F.1
Martin, L.2
De Ceaurriz, J.3
Larcher, T.4
Moullier, P.5
Chenuaud, P.6
-
69
-
-
0035894739
-
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: The retina as a model
-
Auricchio A, Kobinger G, Anand V et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: The retina as a model. Hum. Mol. Genet. 10(26), 3075-3081 (2001).
-
(2001)
Hum. Mol. Genet.
, vol.10
, Issue.26
, pp. 3075-3081
-
-
Auricchio, A.1
Kobinger, G.2
Anand, V.3
-
70
-
-
10744229842
-
Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog and nonhuman primate after subretinal delivery
-
Weber M, Rabinowitz J, Provost N et al. Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog and nonhuman primate after subretinal delivery. Mol. Ther. 7(6), 774-781 (2003).
-
(2003)
Mol. Ther.
, vol.7
, Issue.6
, pp. 774-781
-
-
Weber, M.1
Rabinowitz, J.2
Provost, N.3
-
71
-
-
33645840126
-
Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors
-
Stieger K, Le Meur G, Lasne F et al. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors. Mol. Ther. 13(5), 967-975 (2006).
-
(2006)
Mol. Ther.
, vol.13
, Issue.5
, pp. 967-975
-
-
Stieger, K.1
Le Meur, G.2
Lasne, F.3
-
72
-
-
70349849524
-
Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates
-
Menzel O, Birraux J, Wildhaber BE et al. Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. Mol. Ther. 17(10), 1754-1760 (2009).
-
(2009)
Mol. Ther.
, vol.17
, Issue.10
, pp. 1754-1760
-
-
Menzel, O.1
Birraux, J.2
Wildhaber, B.E.3
-
73
-
-
22644444463
-
Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins
-
Brill-Almon E, Stern B, Afik D et al. Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Mol. Ther. 12(2), 274-282 (2005).
-
(2005)
Mol. Ther.
, vol.12
, Issue.2
, pp. 274-282
-
-
Brill-Almon, E.1
Stern, B.2
Afik, D.3
-
75
-
-
77955664126
-
Gene doping detection: Evaluation of approach for direct detection of gene transfer using erythropoietin as a model system
-
Baoutina A, Coldham T, Bains GS, Emslie KR. Gene doping detection: Evaluation of approach for direct detection of gene transfer using erythropoietin as a model system. Gene Ther. 17(8), 1022-1032 (2010).
-
(2010)
Gene Ther.
, vol.17
, Issue.8
, pp. 1022-1032
-
-
Baoutina, A.1
Coldham, T.2
Bains, G.S.3
Emslie, K.R.4
-
76
-
-
79952484973
-
Direct and long-term detection of gene doping in conventional blood samples
-
Beiter T, Zimmermann M, Fragasso A et al. Direct and long-term detection of gene doping in conventional blood samples. Gene Ther. 18(3), 225-231 (2011).
-
(2011)
Gene Ther.
, vol.18
, Issue.3
, pp. 225-231
-
-
Beiter, T.1
Zimmermann, M.2
Fragasso, A.3
-
77
-
-
79960113180
-
Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: Implications for gene doping
-
Ni W, Le Guiner C, Gernoux G, Penaud- Budloo M, Moullier P, Snyder RO. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: Implications for gene doping. Gene Ther. 18(7), 709-718 (2011).
-
(2011)
Gene Ther.
, vol.18
, Issue.7
, pp. 709-718
-
-
Ni, W.1
Le Guiner, C.2
Gernoux, G.3
Penaud- Budloo, M.4
Moullier, P.5
Snyder, R.O.6
-
78
-
-
84870254053
-
Detection of EPO doping and blood doping: The haematological module of the Athlete Biological Passport
-
doi:10.1002/dta.406 Epub ahead of print
-
Schumacher YO, Saugy M, Pottgiesser T, Robinson N. Detection of EPO doping and blood doping: The haematological module of the Athlete Biological Passport. Drug Test. Anal. doi:10.1002/dta.406 (2012) (Epub ahead of print).
-
(2012)
Drug Test. Anal.
-
-
Schumacher, Y.O.1
Saugy, M.2
Pottgiesser, T.3
Robinson, N.4
|